Clinical Trial Services (Medical Devices)
Various
About Klinsel
Klinsel, established in 2009, is a private limited company and a leading local CRO in Malaysia, offering end-to-end clinical trial management services. The company has extensive experience in conducting international and local studies, with a strong network of clinicians and hospitals. Klinsel's mission is to ensure clinical research projects are conducted with the highest standards, on par with international best practices, while adhering to local guidelines and regulatory requirements. The company is well-positioned to serve as a partner for global studies requiring subject recruitment in Malaysia.
View full company profileAbout Klinsel
Klinsel, established in 2009, is a private limited company and a leading local CRO in Malaysia, offering end-to-end clinical trial management services. The company has extensive experience in conducting international and local studies, with a strong network of clinicians and hospitals. Klinsel's mission is to ensure clinical research projects are conducted with the highest standards, on par with international best practices, while adhering to local guidelines and regulatory requirements. The company is well-positioned to serve as a partner for global studies requiring subject recruitment in Malaysia.
View full company profileAbout Klinsel
Klinsel, established in 2009, is a private limited company and a leading local CRO in Malaysia, offering end-to-end clinical trial management services. The company has extensive experience in conducting international and local studies, with a strong network of clinicians and hospitals. Klinsel's mission is to ensure clinical research projects are conducted with the highest standards, on par with international best practices, while adhering to local guidelines and regulatory requirements. The company is well-positioned to serve as a partner for global studies requiring subject recruitment in Malaysia.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| New Generic Approvals | China SXT Pharmaceuticals | Application Submitted / BE Stage |
| New Dosage Form Development | Universe Pharmaceuticals | Development |
| New TCM Formula Registration | Universe Pharmaceuticals | Development |
| CBD/THC Oil Formulation | Avecho Biotechnology | Preclinical |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |
| Companion Diagnostics Development | Kiffik Biomedical | Pre-clinical |
| Portfolio of Complex Generics & 505(b)(2) Products | Alvogen | Approved/Commercial |
| Portfolio of 40+ products | Praxgen Pharmaceuticals | Development |
| Drug Repositioning Service | Biovista | Service |
| Custom Control Development | Anchor Molecular | Development/Commercial |
| Portfolio from Steriscience Partnership | Armas Pharmaceuticals | ANDA Development/Filing |